Physician profile
Apphia Wang
NPI 1902224553
$4,358.08
in general payments reported to CMS, 2019-2025
25 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,025 · 2020: $599 · 2021: $357 · 2022: $224 · 2023: $15.37 · 2024: $19.87 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $860.64 | 2019-2025 | Skyrizi |
| Novartis Pharmaceuticals Corporation | $730.22 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $561.98 | 2019 | |
| Genzyme Corporation | $370.46 | 2019-2021 | |
| Leo Pharma INC. | $340.94 | 2019-2022 | |
| Allergan, INC. | $257.86 | 2019 | |
| Lilly USA, LLC | $257.25 | 2019-2024 | Taltz |
| Janssen Biotech, INC. | $163.86 | 2019-2021 | |
| Celgene Corporation | $148.88 | 2019 | |
| Pfizer INC. | $119.16 | 2019-2020 | |
| Genentech USA, INC. | $109.43 | 2021 | |
| Kerecis Limited | $88.84 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Amgen INC. | $75.36 | 2020-2022 | |
| Dermira, INC. | $70.81 | 2019 | |
| Organogenesis INC. | $26.83 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $21.96 | 2021 | |
| Almirall LLC | $20.46 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.90 | 2019 | |
| Pierre Fabre Pharmaceuticals, INC. | $18.03 | 2019 | |
| Sun Pharmaceutical Industries INC. | $17.74 | 2021 | |
| Mayne Pharma Commercial LLC | $17.20 | 2019 | |
| Mylan Pharmaceuticals INC. | $17.12 | 2019 | |
| Epi Health, LLC | $15.72 | 2020 | |
| Galderma Laboratories, L.P. | $13.79 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Apphia Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.